Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals
Gespeichert in:
| Veröffentlicht in: | Polskie archiwum medycyny wewne̦trznej 2019-03, Vol.129 (3), p.215-218 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 218 |
|---|---|
| container_issue | 3 |
| container_start_page | 215 |
| container_title | Polskie archiwum medycyny wewne̦trznej |
| container_volume | 129 |
| creator | Fleischer-Stępniewska, Katarzyna Rymer, Weronika S, Inglot, Marcin Zalewska, Małgorzata Knysz, Brygida Inglot, Małgorzata |
| description | |
| doi_str_mv | 10.20452/pamw.4442 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2201710214</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2201710214</sourcerecordid><originalsourceid>FETCH-LOGICAL-c323t-f77422998570552f2a779d00259cdd47015d6c225e99318df19cf935e9bc1f0e3</originalsourceid><addsrcrecordid>eNptkMtKAzEUhoMotlY3PoBkKcLUXJvJUoo3KAii6yHNxUY7MzXJWHwI39mMrdKFq3PhO9-BH4BTjMYEMU4uV6pejxljZA8McSlFIVlJ93f6ATiK8RWhiaSlOAQDigQvKZ4Mwdejj2-wdVB1qfV13TUWLuxKJZ98hMEqnfxHntoG-gb2e9ukCNc-LaBehLbxeoefQtWY_1Upu5I1m0vjg9Wp6OXNS77JP3xQy3gMDlwu9mRbR-D55vppelfMHm7vp1ezQlNCU-GEYIRIWXKBOCeOKCGkQYhwqY1hAmFuJpoQbqWkuDQOS-0kzeNcY4csHYHzjXcV2vfOxlTVPmq7XKrGtl2sCEFYYEQwy-jFBtWhjTFYV62Cr1X4rDCqfuKv-virPv4Mn2293by25g_9zZt-A3bfg70</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2201710214</pqid></control><display><type>article</type><title>Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Fleischer-Stępniewska, Katarzyna ; Rymer, Weronika ; S, Inglot, Marcin ; Zalewska, Małgorzata ; Knysz, Brygida ; Inglot, Małgorzata</creator><creatorcontrib>Fleischer-Stępniewska, Katarzyna ; Rymer, Weronika ; S, Inglot, Marcin ; Zalewska, Małgorzata ; Knysz, Brygida ; Inglot, Małgorzata</creatorcontrib><identifier>ISSN: 1897-9483</identifier><identifier>EISSN: 1897-9483</identifier><identifier>DOI: 10.20452/pamw.4442</identifier><identifier>PMID: 30758316</identifier><language>eng</language><publisher>Poland</publisher><subject>Adult ; Anti-Inflammatory Agents - therapeutic use ; Antiviral Agents - therapeutic use ; Female ; Hepatitis C, Chronic - drug therapy ; Hepatitis C, Chronic - immunology ; Hepatitis, Autoimmune - drug therapy ; Hepatitis, Autoimmune - immunology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Risk Factors ; Treatment Outcome ; Virus Activation - drug effects</subject><ispartof>Polskie archiwum medycyny wewne̦trznej, 2019-03, Vol.129 (3), p.215-218</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c323t-f77422998570552f2a779d00259cdd47015d6c225e99318df19cf935e9bc1f0e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30758316$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fleischer-Stępniewska, Katarzyna</creatorcontrib><creatorcontrib>Rymer, Weronika</creatorcontrib><creatorcontrib>S, Inglot, Marcin</creatorcontrib><creatorcontrib>Zalewska, Małgorzata</creatorcontrib><creatorcontrib>Knysz, Brygida</creatorcontrib><creatorcontrib>Inglot, Małgorzata</creatorcontrib><title>Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals</title><title>Polskie archiwum medycyny wewne̦trznej</title><addtitle>Pol Arch Intern Med</addtitle><subject>Adult</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Female</subject><subject>Hepatitis C, Chronic - drug therapy</subject><subject>Hepatitis C, Chronic - immunology</subject><subject>Hepatitis, Autoimmune - drug therapy</subject><subject>Hepatitis, Autoimmune - immunology</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>Virus Activation - drug effects</subject><issn>1897-9483</issn><issn>1897-9483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkMtKAzEUhoMotlY3PoBkKcLUXJvJUoo3KAii6yHNxUY7MzXJWHwI39mMrdKFq3PhO9-BH4BTjMYEMU4uV6pejxljZA8McSlFIVlJ93f6ATiK8RWhiaSlOAQDigQvKZ4Mwdejj2-wdVB1qfV13TUWLuxKJZ98hMEqnfxHntoG-gb2e9ukCNc-LaBehLbxeoefQtWY_1Upu5I1m0vjg9Wp6OXNS77JP3xQy3gMDlwu9mRbR-D55vppelfMHm7vp1ezQlNCU-GEYIRIWXKBOCeOKCGkQYhwqY1hAmFuJpoQbqWkuDQOS-0kzeNcY4csHYHzjXcV2vfOxlTVPmq7XKrGtl2sCEFYYEQwy-jFBtWhjTFYV62Cr1X4rDCqfuKv-virPv4Mn2293by25g_9zZt-A3bfg70</recordid><startdate>20190329</startdate><enddate>20190329</enddate><creator>Fleischer-Stępniewska, Katarzyna</creator><creator>Rymer, Weronika</creator><creator>S, Inglot, Marcin</creator><creator>Zalewska, Małgorzata</creator><creator>Knysz, Brygida</creator><creator>Inglot, Małgorzata</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20190329</creationdate><title>Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals</title><author>Fleischer-Stępniewska, Katarzyna ; Rymer, Weronika ; S, Inglot, Marcin ; Zalewska, Małgorzata ; Knysz, Brygida ; Inglot, Małgorzata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c323t-f77422998570552f2a779d00259cdd47015d6c225e99318df19cf935e9bc1f0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adult</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Female</topic><topic>Hepatitis C, Chronic - drug therapy</topic><topic>Hepatitis C, Chronic - immunology</topic><topic>Hepatitis, Autoimmune - drug therapy</topic><topic>Hepatitis, Autoimmune - immunology</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>Virus Activation - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fleischer-Stępniewska, Katarzyna</creatorcontrib><creatorcontrib>Rymer, Weronika</creatorcontrib><creatorcontrib>S, Inglot, Marcin</creatorcontrib><creatorcontrib>Zalewska, Małgorzata</creatorcontrib><creatorcontrib>Knysz, Brygida</creatorcontrib><creatorcontrib>Inglot, Małgorzata</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Polskie archiwum medycyny wewne̦trznej</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fleischer-Stępniewska, Katarzyna</au><au>Rymer, Weronika</au><au>S, Inglot, Marcin</au><au>Zalewska, Małgorzata</au><au>Knysz, Brygida</au><au>Inglot, Małgorzata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals</atitle><jtitle>Polskie archiwum medycyny wewne̦trznej</jtitle><addtitle>Pol Arch Intern Med</addtitle><date>2019-03-29</date><risdate>2019</risdate><volume>129</volume><issue>3</issue><spage>215</spage><epage>218</epage><pages>215-218</pages><issn>1897-9483</issn><eissn>1897-9483</eissn><cop>Poland</cop><pmid>30758316</pmid><doi>10.20452/pamw.4442</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1897-9483 |
| ispartof | Polskie archiwum medycyny wewne̦trznej, 2019-03, Vol.129 (3), p.215-218 |
| issn | 1897-9483 1897-9483 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2201710214 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
| subjects | Adult Anti-Inflammatory Agents - therapeutic use Antiviral Agents - therapeutic use Female Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - immunology Hepatitis, Autoimmune - drug therapy Hepatitis, Autoimmune - immunology Humans Male Middle Aged Prospective Studies Risk Factors Treatment Outcome Virus Activation - drug effects |
| title | Risk of autoimmune hepatitis reactivation in patients with chronic hepatitis C and autoimmune hepatitis treated with direct-acting antivirals |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T02%3A32%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20autoimmune%20hepatitis%20reactivation%20in%20patients%20with%20chronic%20hepatitis%20C%20and%20autoimmune%20hepatitis%20treated%20with%20direct-acting%20antivirals&rft.jtitle=Polskie%20archiwum%20medycyny%20wewne%CC%A6trznej&rft.au=Fleischer-St%C4%99pniewska,%20Katarzyna&rft.date=2019-03-29&rft.volume=129&rft.issue=3&rft.spage=215&rft.epage=218&rft.pages=215-218&rft.issn=1897-9483&rft.eissn=1897-9483&rft_id=info:doi/10.20452/pamw.4442&rft_dat=%3Cproquest_cross%3E2201710214%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2201710214&rft_id=info:pmid/30758316&rfr_iscdi=true |